-
1 Comment
BML, Inc is currently in a long term uptrend where the price is trading 11.2% above its 200 day moving average.
From a valuation standpoint, the stock is 98.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
BML, Inc's total revenue rose by 24.3% to $38B since the same quarter in the previous year.
Its net income has increased by 195.0% to $5B since the same quarter in the previous year.
Based on the above factors, BML, Inc gets an overall score of 4/5.
| ISIN | JP3799700004 |
|---|---|
| Industry | Diagnostics & Research |
| Exchange | TSE |
| CurrencyCode | JPY |
| Sector | Healthcare |
| Target Price | 2900 |
|---|---|
| Dividend Yield | 4.3% |
| Market Cap | 111B |
| PE Ratio | 17.7 |
| Beta | 0.26 |
BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures. It also provides medical information system services, which include electronic medical charts for networking medical information, as well as preventive medicine services. In addition, the company offers food sanitation test, including food sanitation control and food processing services, which comprise contract services for microorganism testing of raw materials, and prepared and processed food; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and wastewater tests; work environment services, such as measurement of ethylene oxide gas, formaldehyde, organic solvent, and dust; environmental monitoring, which include measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; human genome analysis services; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4694.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
